Analyst Rating Update on Walgreens Boots Alliance (WBA)

Walgreens Boots Alliance (WBA) : The consensus on Walgreens Boots Alliance (WBA) based on 15 analyst recommendation on the company stock is 1.77, which is interpreted as a Buy recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 8 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 2 analyst believes that the stock is a Buy, which can produce decent returns in the future. 5 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating.

Walgreens Boots Alliance (WBA) stock is expected to deviate a maximum of $6.57 from the average target price of $93.07 for the short term period. 14 Street Experts have initiated coverage on the stock with the most promising target being $103 and the most muted being $79.

For the current week, the company shares have a recommendation consensus of Buy. Also, Equity Analysts at the Keefe Bruyette & Woods downgrades the rating on Walgreens Boots Alliance (NASDAQ:WBA). The brokerage firm has issued a Underperform rating on the shares. The shares were previously rated Market Perform. The rating by the firm was issued on July 22, 2016.


Walgreens Boots Alliance (NASDAQ:WBA): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $79.02 and $78.85 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $80.02. The buying momentum continued till the end and the stock did not give up its gains. It closed at $79.60, notching a gain of 0.82% for the day. The total traded volume was 3,819,116 . The stock had closed at $78.95 on the previous day.

Walgreens Boots Alliance, Inc. (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led health and wellbeing enterprise. It operates through three segments: Retail Pharmacy USA, which consists of the Walgreens business, including the operation of retail drugstores and convenient care clinics, in addition to providing specialty pharmacy services; Retail Pharmacy International, which consists of the Alliance Boots pharmacy-led health and beauty stores, optical practices and related contract manufacturing operations, and Pharmaceutical Wholesale, which consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. Its portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as global health and beauty product brands, including No7, Botanics, and Soap & Glory. Walgreens Boots Alliance, through its subsidiary, Liz Earle Beauty Co. Ltd, offers the Liz Earle skincare brand.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.